Back to Search Start Over

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.

Authors :
Grode, Leander
Seiler, Peter
Baumann, Sven
Hess, Jürgen
Brinkmann, Volker
Eddine, Ali Nasser
Mann, Peggy
Goosmann, Christian
Bandermann, Silke
Smith, Debbie
Bancroft, Gregory J.
Reyrat, Jean-Marc
van Soolingen, Dick
Raupach, Bärbel
Kaufmann, Stefan H. E.
Hess, Jürgen
Nasser Eddine, Ali
Raupach, Bärbel
Source :
Journal of Clinical Investigation. Sep2005, Vol. 115 Issue 9, p2472-2479. 8p. 1 Color Photograph, 5 Graphs.
Publication Year :
2005

Abstract

The tuberculosis vaccine Mycobacterium bovis bacille Calmette-Guérin (BCG) was equipped with the membrane-perforating listeriolysin (Hly) of Listeria monocytogenes, which was shown to improve protection against Mycobacterium tuberculosis. Following aerosol challenge, the Hly-secreting recombinant BCG (hly+ rBCG) vaccine was shown to protect significantly better against aerosol infection with M. tuberculosis than did the parental BCG strain. The isogenic, urease C-deficient hly+ rBCG (DeltaureC hly+ rBCG) vaccine, providing an intraphagosomal pH closer to the acidic pH optimum for Hly activity, exhibited still higher vaccine efficacy than parental BCG. DeltaureC hly+ rBCG also induced profound protection against a member of the M. tuberculosis Beijing/W genotype family while parental BCG failed to do so consistently. Hly not only promoted antigen translocation into the cytoplasm but also apoptosis of infected macrophages. We concluded that superior vaccine efficacy of DeltaureC hly+ rBCG as compared with parental BCG is primarily based on improved cross-priming, which causes enhanced T cell-mediated immunity. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00219738
Volume :
115
Issue :
9
Database :
Academic Search Index
Journal :
Journal of Clinical Investigation
Publication Type :
Academic Journal
Accession number :
18098975
Full Text :
https://doi.org/10.1172/JCI24617